Clinical Trials in Nashville

Showing 12061-12080 of 17,403 trials

Thrombolysis in Pediatric Stroke (TIPS)

NCT01591096

Thrombolysis in Pediatric Stroke (TIPS) is a five-year multi-center international safety and dose-finding study of intravenous (IV) tPA in children with acute ischemic stroke (AIS) to determine the maximal safe dose of intravenous Tissue Plasminogen Activator (IV-tPA) among three doses (0.75. 0.9, 1.0 mg/kg) for children age 2-17 years within 4.5 hours from onset of acute AIS.

Stroke

Seattle Children's Hospital1 participantsStarted Oct 2012

Palo Alto, California, United States • Aurora, Colorado, United States • Boston, Massachusetts, United States +12 more locations

COMPLETEDNA< 1 mile

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

NCT00417989

Primary Outcomes: Average decrease in A1c from baseline to end of Study Phase (52 weeks) for subjects in the "722 Group" is greater than that for subjects in the "Control (MDI) Group". Secondary Outcomes: Incidence and frequency of severe hypoglycemia; Measure of glycemic variability, Area Under the Curve (AUC); Quality of Life; and Health Economic Outcomes (MRU)

Type 1 Diabetes

Medtronic Diabetes485 participantsStarted Jan 2007

La Jolla, California, United States • Orange, California, United States • Boulder, Colorado, United States +27 more locations

Thrombolysis in Pediatric Stroke (TIPS)

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Find Trials by Condition in Nashville

Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Phase 1 and 2 Study of PX-866 and Cetuximab

Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant

PF-00489791 For The Treatment Of Raynaud's

Behavioral & Nutritional Treatment to Help CF Preschoolers Grow

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Vascular Inflammation in Psoriasis - Extension Study

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)